Meet the Partners

The partners at Arch Partners are all accomplished “in the trenches” executives who have successfully founded, funded, run, and sold companies. Each of the partners knows what it’s like to be in the entrepreneur’s shoes, because each of the partners has experienced it directly, more than once!

If your company is selected by Arch Partners, you will have an experienced, accomplished, and skilled set of executives on your side who will roll up their sleeves and get things done for you. Follow a link below for an individual bio or scroll down for all bios:

Managing Partners

Associate Partners


Managing Partners

Emre TokerEmre Toker
Emre.Toker@ArchPartnersLLC.com

Emre started his first technology company, MedOptics Corporation, in 1994 with a personal investment of only $10,000. Utilizing Small Business Innovation Research (SBIR) grants of over $2 million, MedOptics developed new digital imaging systems for the diagnosis and treatment of breast cancer. From 1994 to 2000, MedOptics grew to become a highly profitable company and was acquired in 2000 by DALSA Corporation of Toronto, a Canadian public company, in a multimillion dollar transaction.

In 1998, realizing the potential of CMOS sensors (sensors now used in practically all consumer digital cameras) in the field of digital x-ray imaging, Emre teamed up with one of the leaders of solid state imager design, Mr. Gene Weckler, to form Rad-Icon Imaging Corporation in Silicon Valley. Rad-Icon also became a highly successful company as the leader in CMOS-based x-ray imagers and was subsequently acquired by DALSA Corporation for an undisclosed sum.

In 2001, using the same principles of very low initial investment and leveraging small business research and development grants, Emre started Bioptics Corporation, which developed FDA-cleared imaging systems for breast cancer surgery. Bioptics imaging systems are currently in clinical use in hundreds of hospitals worldwide. Following the award of an exclusive contract to Bioptics by the government of Ireland for the purchase of all of Ireland’s needs for breast cancer specimen radiography systems, Bioptics was acquired by an Irish private investment group based in Washington D.C. at a muiltimillion dollar valuaton.

Emre is currently working on his fourth venture, Surgical Tools, LLC, which is developing novel disposable and capital equipment products to improve the clinical outcomes for breast cancer patients who select lumpectomy over radical mastectomy in the treatment of their breast cancers. Surgical Tools has already been awarded two National Cancer Institute research and development grants to be used toward the development of these unique and innovative products.

Emre has authored and co-authored numerous patents and articles published in scientific and trade journals. He is a member of the Desert Angels and DesertTech, two Tucson-based angel investor groups, as well as a member of Lab-X, a Turkish angel investor group.

Emre has his BA in physics from Reed College, his BSEE from the California Institute of Technology, and his Masters in Electrical Engineering from the University of Arizona.


Base HornerBase Horner
Base.Horner@ArchPartnersLLC.com

Base has substantial deal experience and is an expert in investing, financing, and engineering liquidity events. His accomplishments include:

  • Chairman of the Screening Panel for the Desert Angels
  • Co-founder of US Capital Partners, LLC, a boutique investment banking firm formed to provide middle-market companies with first-class advisory services by senior professionals who have significant Wall Street and operating experience
  • Completion of in excess of $6 billion in financing and advisory transactions for over 100 middle-market private and public companies
    • Financial advisory experience includes sale and divestiture assignments, strategic mergers and acquisitions, leveraged buyouts, recapitalizations, financial restructurings, takeover defense assignments, and valuation and capital structure studies
    • Financing transaction experience includes private placements of common and preferred stock, subordinated and convertible debt, and senior term and revolving credit facilities

For a list of Base’s financial experience, click here.

For a list of Base’s current and past investments, click here.

Base received his BA degree with honors in business economics from the University of California at Santa Barbara and an MBA with honors in finance and marketing from the University of Chicago.


Huw R. JonesHuw R. Jones
Huw.Jones@ArchPartnersLLC.com

Huw is a senior intellectual property attorney at Hayes Soloway PC, with 20 years of experience in law firms and in corporate settings, and concentrates his practice in counseling small and medium-size technology-based companies in the areas of patents, trademarks, licensing, technology transfer, and litigation. Prior to joining the firm, he started two in-house intellectual property departments for corporations, the most recent being Ventana Medical Systems, Inc., and he has significant experience in business development and licensing, IP strategy and IP portfolio management.

Huw started his career as a patent attorney with the law firms of Allegretti, Witcoff, Newitt & McAndrews (Chicago), and Sterne, Kessler, Goldstein & Fox (Washington, D. C.). He began his in-house career as assistant patent counsel at Millipore Corporation, and moved to its spin-out Waters Corporation as sole in-house counsel where he set up the legal function and assisted with Waters’ 1994 initial public offering. Huw joined the Pharmaceutical Division of Bayer Corporation in 1996 where he represented the Biologicals Division in Berkeley, California, and Clayton, North Carolina. In 1999 he founded the Legal Department of Ventana Medical Systems, and has been on the company’s Executive Committee. Mr. Jones guided the development of Ventana’s extensive patent portfolio, and assisted through four separate patent litigations and numerous business development activities. In 2008 the Roche Group purchased the company for $3.4 billion.

Huw received his BA from Bowdoin College (Brunswick, Maine) in chemistry in 1981, a JD from Franklin Pierce Law Center (Concord, New Hampshire) in 1989, and an MBA from the University of Arizona’s Eller College of Management in 2009. He is a Certified Licensing Professional (CLP) through the Licensing Executive’s Society, the preeminent licensing group in the country. Huw is also a member of the American Intellectual Property Law Association, Association of Corporate Counsel, and BIOZONA.

Huw is admitted to the bars of the State of Illinois, the District of Columbia, the United States Patent and Trademark Office, and United States Federal Court (Illinois). He has chaired or spoken at several Arizona forums on intellectual property matters in the recent past and was a faculty presenter at the Arizona State Bar Convention in June 2008 on the topic of  “Intellectual Property Contracts.”

Huw is a member of the Arizona Desert Angels, a Tucson-based private group of angel investors, where he is also active on the Screening Panel for new ventures.


David C. SmallhouseDavid C. Smallhouse
david.smallhouse@archpartnersllc.com

Currently David is the Managing Partner in Miramar Ventures, LLC, a firm involved in real estate, private equity, and venture capital investments. Miramar Ventures is an active investor in angel and early stage ventures. Its portfolio includes bio science, drug development, life science, clean tech, and medical device companies, many with close ties to the University of Arizona and/or the Desert Angels of Southern Arizona.

David began his career as in agribusiness lending with Bank of America in Brawley, California, as an assistant vice president. He also served as an assistant vice president with Valley National Bank and as Vice President of Commercial Loans at Citibank in Tucson. He was a member of the CFO’s direct staff at Burr-Brown Corporation and one of two founders of Comercial del Mayo in Navojoa, Sonora, Mexico, a business partnership active in the importation of construction materials and exportation of agricultural commodities to the United States and Asia.

A fifth-generation Tucsonan, David graduated from the University of California at Davis with a BS in agricultural economics and the University of Arizona with an MS in agricultural economics. He currently serves as an Executive Board Member of Desert Angels and recently became a member of the Arch Partners team. Civic activities include being a trustee of the Arizona-Sonora Desert Museum and a member of the Tucson Airport Authority and the DM50.


Associate Partners

Chuck BolotinChuck Bolotin
Chuck.Bolotin@ArchPartnersLLC.com

Chuck is a “go to market” expert with experience in several diverse markets. He founded his first successful business when he was 15 years old. At the age of 23, he joined a commercial office equipment reseller. Within 5 years,he had become Vice President of Business Development, Marketing, and Sales, transformed the business, and had increased revenues in excess of 800%, with an 1,100% increase in earnings.

By the age of 28, Chuck founded and became CEO of Office Solutions, Inc., which, through several groundbreaking industry-first strategic alliances and his development and implementation of a highly successful consultative sales program, achieved industry-leading sales and overall financial performance (32% pre-tax profit).

After selling Office Solutions, Chuck founded and became CEO of InterMed Software, Inc., a company that created clinical automation software to run on a pen-based notebook PC. Chuck secured debt and equity financing, identified and negotiated with a strategic partner (a public company) that also brought in working capital, identified the eventual buyer, and negotiated the sale of InterMed Software in 1999.

In 2005, Chuck joined BioVigilant Systems (a venture-funded start-up) as Vice President, Marketing and Sales, with the charter to determine if the company’s IP had value in markets then unknown to the company. Within two months, Chuck identified a potential $2 billion+ market selling to pharmaceutical manufacturers. Chuck defined the “go to market” strategy and executed it with what was, at first, a small team. Achievements included forming a Consortium of 14 of the largest pharmaceutical manufacturers in the world, successful execution of the ongoing FDA submission strategy, and initial sales to 13 pharmaceutical manufacturers (also some of the largest in the world). Chuck left BioVigilant as Vice President, Pharma Business Unit.

In 2008, Chuck Founded On Target Consultants, specializing in “go to market” strategy and execution. In addition to being a founding Senior Partner of Arch Partners, Chuck also applies his knowledge and experience as a frequent lecturer at the Eller College of Management MBA Program, University of Arizona; and as a business mentor at the Arizona Center for Innovation.

Chuck received his BA in business economics with highest honors at the University of California at Santa Barbara.

Comments are closed.